Changes in testosterone prescribing patterns after FDA warning

Journal article

Open access

Peer reviewed

Soum D Lokeshwar, Joshua Bitran and Ranjith Ramasamy

Translational andrology and urology, Vol.8(Suppl 3), pp.S287-S288

2019-07

PMCID: PMC6642974

PMID: 31392147

Files and links (1)

url

https://doi.org/10.21037/tau.2019.04.03View

Published (Version of record) Open

11 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics: 1 Clinical & Life Sciences; 1.141 Hormone Therapy; 1.141.1092 Testosterone
Web Of Science research areas: Andrology; Urology & Nephrology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Changes in testosterone prescribing patterns after FDA warning
Creators: Soum D Lokeshwar - Department of Urology, University of Miami, Miami, FL, USA
Joshua Bitran - Department of Urology, University of Miami, Miami, FL, USA
Ranjith Ramasamy - Department of Urology, University of Miami, Miami, FL, USA
Publication Details: Translational andrology and urology, Vol.8(Suppl 3), pp.S287-S288
Academic Unit: Miller School of Medicine; UMMG Department of Urology
Language: English
Resource Type: Journal article
PMID: 31392147
PMCID: PMC6642974
Record Identifier: 991031597627602976